GALMED PHARMACEUTICALS LTD's ticker is GLMD and the CUSIP is M47238106. A total of 21 filers reported holding GALMED PHARMACEUTICALS LTD in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $5,000 | +25.0% | 1,815 | +46.3% | 0.00% | – |
| Q2 2021 | $4,000 | -55.6% | 1,241 | -51.7% | 0.00% | – |
| Q1 2021 | $9,000 | -65.4% | 2,568 | -69.1% | 0.00% | -100.0% |
| Q4 2020 | $26,000 | -25.7% | 8,301 | -17.2% | 0.00% | – |
| Q3 2020 | $35,000 | +600.0% | 10,027 | +547.7% | 0.00% | – |
| Q1 2020 | $5,000 | -86.5% | 1,548 | -75.5% | 0.00% | -100.0% |
| Q4 2019 | $37,000 | -2.6% | 6,328 | +21.5% | 0.00% | 0.0% |
| Q2 2019 | $38,000 | +660.0% | 5,207 | +796.2% | 0.00% | – |
| Q1 2019 | $5,000 | – | 581 | +1389.7% | 0.00% | – |
| Q4 2018 | $0 | -100.0% | 39 | -89.5% | 0.00% | – |
| Q3 2018 | $5,000 | +400.0% | 370 | +85.0% | 0.00% | – |
| Q2 2017 | $1,000 | – | 200 | +244.8% | 0.00% | – |
| Q3 2016 | $0 | -100.0% | 58 | -81.2% | 0.00% | – |
| Q2 2016 | $1,000 | 0.0% | 308 | +242.2% | 0.00% | – |
| Q3 2015 | $1,000 | -83.3% | 90 | -85.9% | 0.00% | -100.0% |
| Q1 2015 | $6,000 | -25.0% | 638 | -50.7% | 0.00% | 0.0% |
| Q4 2014 | $8,000 | -57.9% | 1,294 | -33.4% | 0.00% | -50.0% |
| Q2 2014 | $19,000 | +26.7% | 1,942 | +51.4% | 0.00% | 0.0% |
| Q1 2014 | $15,000 | – | 1,283 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 202,100 | $2,318,000 | 1.99% |
| Gerry Farber, LLC | 52,000 | $596,000 | 1.03% |
| Granite Point Capital Management, L.P. | 115,000 | $1,319,000 | 0.94% |
| 683 Capital Management, LLC | 158,735 | $1,821,000 | 0.71% |
| SPHERA FUNDS MANAGEMENT LTD. | 170,000 | $1,950,000 | 0.44% |
| Knoll Capital Management, LLC | 65,000 | $746,000 | 0.39% |
| Healthcare Value Capital, LLC | 50,000 | $574,000 | 0.38% |
| Park West Asset Management LLC | 200,000 | $2,294,000 | 0.26% |
| Perceptive Advisors | 75,000 | $860,000 | 0.09% |
| HIGHLAND CAPITAL MANAGEMENT LP | 126,956 | $1,456,000 | 0.06% |